Techniques for the evaluation of nucleic acid amplification technology performance with specimens containing interfering substances: Efficacy of Boom methodology for extraction of HIV-1 RNA

Journal of Virological Methods

Volumn 79, Issue 1, 1999, Pages 97-111

  Witt, Donald J ^a   Kemper, M ^b  

^a Organon Teknika Corporation   (United States)

^b Sacramento Medical Foundation Blood Center   (United States)

Author keywords

Boom methodology; HIV 1; Interference; Nucleic acid extraction; Viral load testing

Indexed keywords

NUCLEIC ACID; VIRUS RNA; ZIDOVUDINE;

ARTICLE; EXTRACTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; METHODOLOGY; PRIORITY JOURNAL; TECHNIQUE; VIRUS LOAD;

ANTI-HIV AGENTS; ANTICOAGULANTS; BACTERIA; EVALUATION STUDIES; HIV INFECTIONS; HIV SERONEGATIVITY; HIV-1; HUMANS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; VIRAL LOAD;

EID: 0032910595     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(99)00011-7     Document Type: Article

References (18)

1. Akane A., Matsubara K., Nakamura H., Takahashi S., Kimura K. Identification of the heme compound copurified with deoxyribonucleic acid (DNA) from bloodstains, a major inhibitor of polymerase chain reaction (PCR) amplification. J. Forensic Sci. 2:1994;363-372.
2. Anon., 1987. Interference Testing in Clinical Chemistry. National Committee for Clinical Laboratory Standards (Villanova, PA), Doc. EP7-P. Vol. 6(13), 107 pp.
3. Beutler E., Gelbart T., Kuhl W. Interference of heparin with polymerase chain reaction. BioTechniques. 90:1990;166-167.
4. Boom R., Sol C.J.A., Salimans M.M.M., Jansen C.L., Wertheim-van Dillen P.M.E., van der Noordaa J. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28:1990;495-503.
5. Carpenter C.C., Fischl M.A., Hammer S.M., Hirsch M.S., Jacobsen D.M., Katzenstein D.A., Montaner J.S.G., Richman D.D., Saag M.S., Schooley R.T., Thompson M.A., Vella S., Yeni P.G., Volberding P.A. Antiretroviral therapy for HIV infection in 1998: Updated recommendations of the International AIDS Society-USA Panel. J. Am. Med. Assoc. 280:1998;78-86.
6. Centers for Disease Control and Prevention (CDC), 1998. Report of the NIH Panel to Define Principles of Therapy of HIV Infection and Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents. MMWR 47(No. RR-5), 1-82.
7. Forbes B.A., Hicks K.E. Substances interfering with direct detection of Mycobacterium tuberculosis in clinical specimens by PCR: effects of bovine serum albumin. J. Clin. Microbiol. 34:1996;2125-2128.
8. Ginocchio C.C., Wang X.P., Kaplan M.H., Mulligan G., Witt D., Romano J.W., Cronin M., Carroll R. Effects of specimen collection, processing, and storage conditions on stability of Human Immunodeficiency Virus Type 1 RNA levels in plasma. J. Clin. Microbiol. 35:1997;2886-2893.
9. Griffith B.P., Rigsby M.O., Garner R.B., Gordon M.M., Chacko T.M. Comparison of the AMPLICOR HIV-1 Monitor test and the Nucleic Acid Sequence-Based Amplification Assay for quantitation of Human Immunodeficiency Virus RNA in plasma, serum, and plasma subjected to freeze-thaw cycles. J. Clin. Microbiol. 35:1997;3288-3291.
10. Holodniy M., Kim S., Katzenstein D., Konrad M., Groves E., Merigan T.C. Inhibition of human immunodeficiency virus gene amplification by heparin. J. Clin. Microbiol. 29:1991;676-679.
11. Ijzerman M.M., Dahling D.R., Fout G.S. A method to remove environmental inhibitors prior to the detection of waterborne enteric viruses by reverse transcription-polymerase chain reaction. J. Virol. Methods. 63:1997;145-153.
12. Makowski G.S., Davis E.L., Hopfer S.M. Amplification of Guthrie card DNA: effect of guanidine thiocyanate on binding of natural whole blood PCR inhibitors. J. Clin. Lab. Anal. 11:1997;87-93.
13. Monteiro L., Bonnemaison D., Vekris A., Petry K.G., Bonnet J., Vidal R., Cabrita J., Megraud F. Complex polysaccharides as PCR inhibitors in feces: Helicobacter pylori model. J. Clin. Microbiol. 35:1997;995-998.
14. Morandi P.-A., Schockmel G.A., Yerly S., Burgisser P., Erb P., Matter L., Sitavanc R., Perrin L. Detection of Human Immunodeficiency Virus Type 1 (HIV-1) RNA in pools of sera negative for antibodies to HIV-1 and HIV-2. J. Clin. Microbiol. 36:1998;1534-1538.
15. van Gemen B., van Beuningen R., Nabbe A., van Strijp D., Jurriaans S., Lens P., Kievits T. A one-tube quantitative HIV-1 RNA NASBA nucleic acid amplification assay using electrochemiluminescence (ECL) labeled probes. J. Virol. Methods. 49:1994;157-168.
16. Wiedbrauk D.L., Werner J.C., Drevon A.M. Inhibition of PCR by aqueous and vitreous fluids. J. Clin. Microbiol. 33:1995;2643-2646.
17. Yamaguchi Y., Hironaka T., Kajiwara M., Tateno E., Kita H., Hirai K. Increased sensitivity for detection of human cytomegalovirus in urine by removal of inhibitors for the polymerase chain reaction. J. Virol. Methods. 37:1992;209-218.
18. Yedidag E.N., Koffron A.J., Mueller K.H., Kaplan B., Kaufman D.B., Fryer J.P., Stuart F.P., Abecassis M. Acyclovir triphosphate inhibits the diagnostic polymerase chain reaction for cytomegalovirus. Transplantation. 62:1996;238-242.